Evidence map›Paper›PMID 30179994›Full record

ArticleJournal of lower genital tract disease2018

Preference for Human Papillomavirus Self-Collection and Papanicolaou: Survey of Underscreened Women in North Carolina.

Kimberly A Kilfoyle, Andrea C Des Marais, Mai Anh Ngo, LaHoma Romocki, Alice R Richman, Lynn Barclay, Noel T Brewer, Lisa Rahangdale, Jennifer S Smith

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of lower genital tract disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 5 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 5 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Variation in Cervical Cancer Screening Preferences among Medically Underserved Individuals in the United States: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kimberly A KilfoyleDepartment of Obstetrics & Gynecology, Cambridge Health Alliance, Cambridge, MA.
Andrea C Des MaraisDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
Mai Anh NgoDepartment of Biostatistics, Synteract, Inc., Morrisville, NC.
LaHoma RomockiNorth Carolina Central University, Durham, NC.
Alice R RichmanEast Carolina University, Greensville, NC.
Lynn BarclayAmerican Sexual Health Association, Research Triangle Park, NC.
Noel T BrewerDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
Lisa RahangdaleLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
Jennifer S SmithDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
University of North Carolina at Chapel Hill · USCambridge Health Alliance · USEast Carolina University · USNorth Carolina Central University · USTriangle · US

Funding

Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156733 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAJOR, MICHAEL BENJAMIN · 2010 to 2020
$9.7M
Training in Epidemiology and Clinical Trials (TECT)T32HD040672 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOGGESS, KIM A · 2001 to 2015
$4.2M
Effect of HPV Self-Collection on Cervical Cancer Screening in High Risk WomenR01CA183891 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SMITH, JENNIFER SUSAN · 2015 to 2019
$3.0M
NCI NIH HHS R01 CA183891NCI NIH HHS U54 CA156733NCI NIH HHS U54 CA156735NICHD NIH HHS T32 HD040672
6 · The paper itself

Abstract

objectivesSelf-collection of samples for human papillomavirus (HPV) testing (self-collection) has the potential to increase cervical cancer screening among underscreened women. We assessed attitudes toward at-home HPV self-collection compared with clinic-based Pap testing in this higher-risk population. MATERIALS AND

methodsParticipants were low-income women in North Carolina overdue for cervical cancer screening. Women self-collected samples at home, returned samples by mail for HPV testing, and completed phone questionnaires about at-home HPV self-collection. Participants were referred to clinic-based Pap testing and invited to complete a second questionnaire about Pap testing. A cross-sectional questionnaire compared attitudes, experiences, and preferences for self-collection versus Pap testing and assessed predictors of preference for HPV self-collection.

resultsHalf (51%) of 221 women reported a preference for HPV self-collection, 19% preferred Pap testing, and 27% reported no preference. More women reported difficulty finding time to do the Pap test (31%) than the self-test (13%, p = .003) and being afraid of the self-test results (50%) than the Pap test results (36%, p = .02). There were relatively fewer reports of physical discomfort and pain from self-collection than Pap testing (discomfort: 18% self; 48% Pap; pain: 8% self; 30% Pap, p = .001). No differences were found in positive versus negative thoughts about the tests, trust in the tests' safety and accuracy, or willingness to do tests again.

conclusionsOverall positive attitudes toward HPV self-collection compared with Pap testing among underscreened women suggest that self-collection is a promising option to increase cervical cancer screening in this high-risk population.

Indexed as

Patient Acceptance of Health CareSelf AdministrationAdultAgedCross-Sectional StudiesEarly Detection of CancerFemaleHumansMiddle AgedNorth CarolinaPapanicolaou TestPapillomavirus InfectionsSpecimen HandlingSurveys and QuestionnairesUterine Cervical Neoplasms

Identifiers

PMID30179994
PMCPMC6174678
OpenAlexW2888870250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.